Decoding the roles of heat shock proteins in liver cancer.

Diagnosis Heat shock protein Hepatocellular carcinoma Therapy Tumorigenesis

Journal

Cytokine & growth factor reviews
ISSN: 1879-0305
Titre abrégé: Cytokine Growth Factor Rev
Pays: England
ID NLM: 9612306

Informations de publication

Date de publication:
26 Dec 2023
Historique:
received: 14 11 2023
revised: 19 12 2023
accepted: 22 12 2023
medline: 6 1 2024
pubmed: 6 1 2024
entrez: 5 1 2024
Statut: aheadofprint

Résumé

Hepatocellular carcinoma (HCC) is one of the most common gastrointestinal malignancies, characterized by insidious onset and high propensity for metastasis and recurrence. Apart from surgical resection, there are no effective curative methods for HCC in recent years, due to resistance to radiotherapy and chemotherapy. Heat shock proteins (HSP) play a crucial role in maintaining cellular homeostasis and normal organism development as molecular chaperones for intracellular proteins. Both basic research and clinical data have shown that HSPs are crucial participants in the HCC microenvironment, as well as the occurrence, development, metastasis, and resistance to radiotherapy and chemotherapy in various malignancies, particularly liver cancer. This review aims to discuss the molecular mechanisms and potential clinical value of HSPs in HCC, which may provide new insights for HSP-based therapeutic interventions for HCC.

Identifiants

pubmed: 38182465
pii: S1359-6101(23)00090-4
doi: 10.1016/j.cytogfr.2023.12.003
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Chen Sun (C)

Department of Radiology, Shengjing Hospital of China Medical University, Shenyang 110004, China.

Qi Pan (Q)

Department of Hepatobiliary Surgery and Organ Transplantation, First Hospital of China Medical University, Shenyang 110004, China.

Mingyang Du (M)

Department of Radiology, Shengjing Hospital of China Medical University, Shenyang 110004, China.

Jiahe Zheng (J)

Department of Radiology, Shengjing Hospital of China Medical University, Shenyang 110004, China.

Ming Bai (M)

Second Department of Medical Oncology, the First Hospital of China Medical University, Shenyang 110001, China. Electronic address: mbai@cmu.edu.cn.

Wei Sun (W)

Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China. Electronic address: sunwei_sjhospital@163.com.

Classifications MeSH